Kidney Care Quality and Education Act of 2007

H. R. 1193, Kidney Care Quality and Education Act of 2007 S. 691, Kidney Care Quality and Education Act of 2007

Client expense: Not reported · Firm income: $90,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H. R. 1193, Kidney Care Quality and Education Act of 2007 S. 691, Kidney Care Quality and Education Act of 2007 H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008

Client expense: Not reported · Firm income: $90,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions H.R. 5480 Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B Drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provision Comparative Effectiveness S. 2099 "Preserving Access to Laboratory Services Act of 2007" Repeal of Competitive bidding demo ESRD "bundling issues" and ESRD drug reimbursement issues Medicare prescription drug benefit H.R. 1321 "Medicare Advanced Laboratory Diagnostic Act of 2007" S. 691/H.R. 1193 The Kidney Care Quality and Education Act CPT Coding decisions and HCPCS coding decisions Reimbursement for Part B Drugs administered in hospital out patient departments, dialysis centers and physician officers Physicians fee schedule payment rates for lab tests. Medicaid rebates H.R. 2184, The Enhanced health Care Value for All Act H.R. 6331 "Medicare Improvements for Patients and Providers Act of 2008" S. 3101, "Medicare Improvements for Patients and Providers Act of 2008" MIPPA Technical Connections H.R. 1472 Emergency Economic Stabilization Act of 2008

Client expense: $658,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S 1408, Health Information Technology Act of 2007, Sections requiring the Department of Health and Human Services to establish a program to utilize health Information electronic technology to improve delivery and care to patients S 1693, Wired for Health Care Quality Act, Sections requiring the Department of Health and Human Services to establish a program to utilize health Information electronic technology to improve delivery and care to patients S 1695, Biologics Price Competition and Innovation Act of 2007, Sections regarding interchangeability, patent and exclusivity issues related to Food and Drug Administration approval of biogeneric drugs. S 691/ HR 1193, Kidney Care Quality and Educations Act of 2007, Section regarding increased costs to employers health plans. HR 5629, The Pathway for Biosimilars Act, Sections regarding interchangeability, patent and exclusivity issues related to Food and Drug Administration approval of biogeneric drugs. S 1082, Food and Drug Administration Revitalization Act, Provisions related to generic pharmaceuticals HR 2900, Food and Drug Administration Amendments Act of 2007, Provisions related to generic pharmaceuticals HR1 of 2003, Medicare Modernization Act, Employee Medicare Prescription Drug Subsidy

Client expense: $1,925,000 · Firm income: Not reported

Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Export-Import Bank of the United States (EXIM Bank), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office

S 1695, Biologics Price Competition and Innovation Act of 2007, Sections regarding interchangeability, patent and exclusivity issues related to Food and Drug Administration approval of biogeneric drugs. S 691/ HR 1193, Kidney Care Quality and Educations Act of 2007, Section regarding increased costs to employers health plans. HR 5629, The Pathway for Biosimilars Act, Sections regarding interchangeability, patent and exclusivity issues related to Food and Drug Administration approval of biogeneric drugs. S 1082, Food and Drug Administration Revitalization Act, Provisions related to generic pharmaceuticals HR 2900, Food and Drug Administration Amendments Act of 2007, Provisions related to generic pharmaceuticals

Client expense: $1,925,000 · Firm income: Not reported

Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Export-Import Bank of the United States (EXIM Bank), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office

Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499); H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 (Public Law No: 110-275); S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008

Client expense: Not reported · Firm income: $150,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid Reform; Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499); H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 (Public Law No: 110-275); S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008

Client expense: Not reported · Firm income: $150,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499); H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008; S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid Reform; Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S.2499); H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008; S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 6331/S.3101 Medicare Improvements for Patients and Providers Act of 2008; S.3144/HR 6252 Medicare DMEPOS Competitive Acquisition Reform Act of 2008; Delay in competitive bidding for DME and supplies; Medicare Advantage; Comparative Effectiveness; ESRD; E-Prescribing; HR 4296/S 2408 Medicare Electronic Medication and Safety Protection Act of 2007 (E-MEDS); S. 691/HR 1193 Kidney Care Quality & Education Act of 2007; Special Need Plans (SNPs); H.R. 5613 Protecting the Medicaid Safety Net Act of 2008

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 6331/S.3101 Medicare Improvements for Patients and Providers Act of 2008; Medicare Advantage; Comparative Effectiveness; ESRD; E-Prescribing; HR 4296/S 2408 Medicare Electronic Medication and Safety Protection Act of 2007 (E-MEDS); S. 691/HR 1193.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Kidney Care Quality and Education Act of 2007 (S. 691/H.R 1193)

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

H.R.1193/S.691 Kidney Care Quality and Education Act of 2007

Client expense: $180,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R.1193/S.691 Kidney Care Quality and Education Act of 2007

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 3162, Children's Health and Medicare Protection Act of 2007 S. 1693, Wired for Health Care Quality Act H.R. 2991, Independent Health Record Trust Act S. 691/H.R. 1193, Kidney Care Quality and Education Act of 2007 S. 2785, Save Medicare Act of 2008 H.R. 6331, Medicare Improvement for Patients and Providers Act of 2008

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 3162, Children's Health & Medicare Protection Act of 2007 (Medicare Payment/Reimbursement Reform); S.1218/HR 2034, Medicare for All Act (Medicare "buy-in"); S. 130/HR 1990, Medicare Cost Contract Extension & Retirement Act of 2007 (private sector role in Medicare); S 3/HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 (Government Negotiation of Medicare Drug Prices); S 1102, Part D Equity for Low Income Seniors Act of 2007 (Special benefits for low income seniors); HR 1663, Medicare Mental Health Modernization Act of 2007 (Medicare Mental Health Parity); HR 976, Children's Health Insurance Program Reauthorization Act of 2007 (SHIP Extension and Expansion); HR 2184, Enhanced Health Care Value for All Act of 2007 (Comparative Effectiveness Research Institute; HR 971, Community Pharmacy Fairness Act of 2007 (Medicare Pharmacist Antitrust Exemption), HR 4327, Medicare Chronic Care Practice Network (Establish a Medicare Chronic Care Practice Research Network to develop and evaluate evidence based chronic care management for Medicare beneficiaries); HR 1193, Kidney Care Quality and Education Act of 2007 (Modernize and improve the Medicare ESRD program); HR 6331, Electronic Prescription in Medicare; HR 6331, Medicare Improvements Act of 2008 (dealing with physician reimbursements and Medicare Advantage funding cuts); H. Res. 1368, Medicare "trigger" to warn against funding problem.

Client expense: $517,594 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

H. R. 1193, Kidney Care Quality and Education Act of 2007 S. 691, Kidney Care Quality and Education Act of 2007 H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008

Client expense: Not reported · Firm income: $90,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H. R. 1193, Kidney Care Quality and Education Act of 2007 S. 691, Kidney Care Quality and Education Act of 2007

Client expense: Not reported · Firm income: $90,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 1695, Biologics Price Competition and Innovation Act of 2007, Sections regarding interchangeability, patent and exclusivity issues related to Food and Drug Administration approval of biogeneric drugs. S 691/ HR 1193, Kidney Care Quality and Educations Act of 2007, Section regarding increased costs to employers health plans. HR 5629, The Pathway for Biosimilars Act, Sections regarding interchangeability, patent and exclusivity issues related to Food and Drug Administration approval of biogeneric drugs. S 1082, Food and Drug Administration Revitalization Act, Provisions related to generic pharmaceuticals HR 2900, Food and Drug Administration Amendments Act of 2007, Provisions related to generic pharmaceuticals

Client expense: $1,925,000 · Firm income: Not reported

Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE

S 1218/ HR 2034, Medicare for All Act, Amending the Social Security Act to add a new Title (XXII) to expand health care coverage S 1408, Health Information Technology Act of 2007, Sections requiring the Department of Health and Human Services to establish a program to utilize health Information electronic technology to improve delivery and care to patients S 1693, Wired for Health Care Quality Act, Sections requiring the Department of Health and Human Services to establish a program to utilize health Information electronic technology to improve delivery and care to patients S 1695, Biologics Price Competition and Innovation Act of 2007, Sections regarding interchangeability, patent and exclusivity issues related to Food and Drug Administration approval of biogeneric drugs. S 691/ HR 1193, Kidney Care Quality and Educations Act of 2007, Section regarding increased costs to employers health plans. HR 5629, The Pathway for Biosimilars Act, Sections regarding interchangeability, patent and exclusivity issues related to Food and Drug Administration approval of biogeneric drugs. S 1082, Food and Drug Administration Revitalization Act, Provisions related to generic pharmaceuticals HR 2900, Food and Drug Administration Amendments Act of 2007, Provisions related to generic pharmaceuticals HR1 of 2003, Medicare Modernization Act, Employee Medicare Prescription Drug Subsidy

Client expense: $1,925,000 · Firm income: Not reported

Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE

H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions H.R. 5480 Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B Drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provision Comparative Effectiveness S. 2099 "Preserving Access to Laboratory Services Act of 2007" Repeal of Competitive bidding demo ESRD "bundling issues" and ESRD drug reimbursement issues Medicare prescription drug benefit H.R. 1321 "Medicare Advanced Laboratory Diagnostic Act of 2007" S. 691/H.R. 1193 The Kidney Care Quality and Education Act CPT Coding decisions and HCPCS coding decisions Reimbursement for Part B Drugs administered in hospital out patient departments, dialysis centers and physician officers Physicians fee schedule payment rates for lab tests. Medicaid rebates H.R. 2184, The Enhanced health Care Value for All Act H.R. 6331 "Medicare Improvements for Patients and Providers Act of 2008" S. 3101, "Medicare Improvements for Patients and Providers Act of 2008" MIPPA Technical Connections H.R. 1472 Emergency Economic Stabilization Act of 2008

Client expense: $770,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 691/H.R. 1193, The Kidney Care Quality and Education Act of 2007. H.R. 6331: "Medicare Improvements for Patients and Providers Act of 2008" ; Sections 152, 153, 164. Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2009; and Revisions to the Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; Proposed Rule" (CMS-1403-P, 07/07/2008) Re: Section II.H. Provisions Related to Payment for Renal Dialysis Services Furnished by End-Stage Renal Disease (ESRD) Facilities;" Re: Section II.N.2: "Physician Self Referral and Anti-Markup Issues: Exception for Incentive Payment and Shared Savings Programs;" Transactions contemplated in Federal Trade Commission Decisions and Orders.

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE

Kidney care education, Medicare ESRD reimbursement and policy, including provisions in: H.R. 6331, the Medicare Improvements for Patients and Providers Act; H.R. 1193/S. 691, the Kidney Care Quality and Education Act of 2007

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Kidney care education, Medicare ESRD reimbursement and policy, including provisions in: H.R. 6331, the Medicare Improvements for Patients and Providers Act; H.R. 1193/S. 691, the Kidney Care Quality and Education Act of 2007

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Kidney care education, Medicare ESRD reimbursement and policy, including provisions in: H.R. 6331, the Medicare Improvements for Patients and Providers Act; H.R. 1193/S. 691, the Kidney Care Quality and Education Act of 2007

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.1193/S.691 Kidney Care Quality and Education Act of 2007

Client expense: $155,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1245/S. 432, Kidney Disease Educational Benefits Act of 2007 regarding Medicare and Medicaid reimbursement issues including Medicaid Rebate and Kidney Disease Education H.R. 1193/S. 691, The Kidney Care Quality and Improvement Act of 2007 regarding all issues related to Medicare coverage of pre-ESRD education H.R. 2914/S. 2990, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services H.R. 5605/S. 2029, Physician Payments Sunshine Act of 2007 H.R. 6331/S. 3101, Medicare Improvements for Patients and Providers Act, as it relates to pre-dialysis education for certain Medicare beneficiaries S. 3118, Preserving Access to Medicare Act of 2008, as it relates to pre-dialysis education for certain Medicare beneficiaries S. 558, Mental Health Parity Act of 2007, as it relates to Medicaid rebates H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007, as it relates to Medicaid rebates Drug and biological product pricing and reimbursement Durable Medical Equipment (DME) payment Product Payment Issues Therapy Payment Issues

Client expense: $720,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Kidney care education, Medicare ESRD reimbursement and policy, including provisions in: H.R. 6331, the Medicare Improvements for Patients and Providers Act; H.R. 1193/S. 691, the Kidney Care Quality and Education Act of 2007

Client expense: $1,116,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Kidney care education, Medicare ESRD reimbursement and policy, including provisions in: H.R. 6331, the Medicare Improvements for Patients and Providers Act; H.R. 1193/S. 691, the Kidney Care Quality and Education Act of 2007

Client expense: $1,116,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Kidney care education, Medicare ESRD reimbursement and policy, including provisions in: H.R. 6331, the Medicare Improvements for Patients and Providers Act; H.R. 1193/S. 691, the Kidney Care Quality and Education Act of 2007

Client expense: $1,116,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Kidney Care Quality and Education Act of 2007 (S. 691/H.R 1193)

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499); H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 (Public Law No: 110-275); S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008

Client expense: Not reported · Firm income: $160,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid Reform; Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499); H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 (Public Law No: 110-275); S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008

Client expense: Not reported · Firm income: $160,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S. 2499); H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008; S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid Reform; Implementation of Medicare Modernization Act; Kidney Care Quality and Education Act (H.R. 1193/S. 691); Health care quality; pay-for-performance; prevention and wellness; The Children's Health and Medicare Protection (CHAMP) Act of 2007 (H.R. 3162); The Medicare, Medicaid, and SCHIP Extension Act of 2007 (S.2499); H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008; S.3101, Medicare Improvements for Patients and Providers Act of 2008; S.3118, Preserving Access to Medicare Act of 2008

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

**see addendum page Medicare Physician Reimbursement Package, Medicaid, and Medicare Bundling and Reimbursement Issues H.R. 6331/S. 3101 - Medicare Improvements for Patients and Providers Act of 2008 S. 3118 - Preserving Access to Medicare Act of 2008 ESRD Quality and Payment Issues S. 691/H.R. 1193 - Kidney Care Quality and Education Act of 2007

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office

HR 3162, Children's Health & Medicare Protection Act of 2007 (Medicare Payment/Reimbursement Reform); S.1218/HR 2034, Medicare for All Act (Medicare "buy-in"); S. 130/HR 1990, Medicare Cost Contract Extension & Retirement Act of 2007 (private sector role in Medicare); S 3/HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 (Government Negotiation of Medicare Drug Prices); S 1102, Part D Equity for Low Income Seniors Act of 2007 (Special benefits for low income seniors); HR 1663, Medicare Mental Health Modernization Act of 2007 (Medicare Mental Health Parity); HR 976, Children's Health Insurance Program Reauthorization Act of 2007 (SHIP Extension and Expansion); HR 2184, Enhanced Health Care Value for All Act of 2007 (Comparative Effectiveness Research Institute; HR 971, Community Pharmacy Fairness Act of 2007 (Medicare Pharmacist Antitrust Exemption), HR 4327, Medicare Chronic Care Practice Network (Establish a Medicare Chronic Care Practice Research Network to develop and evaluate evidence based chronic care management for Medicare beneficiaries); HR 1193, Kidney Care Quality and Education Act of 2007 (Modernize and improve the Medicare ESRD program); HR 6331, Electronic Prescription in Medicare; HR 6331, Medicare Improvements Act of 2008 (dealing with physician reimbursements and Medicare Advantage funding cuts); H. Res. 1368, Medicare "trigger" to warn against funding problem.

Client expense: $452,449 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

H.R. 3162, Children's Health and Medicare Protection Act of 2007 S. 1693, Wired for Health Care Quality Act H.R. 2991, Independent Health Record Trust Act S. 691/H.R. 1193, Kidney Care Quality and Education Act of 2007 S. 2785, Save Medicare Act of 2008 H.R. 6331, Medicare Improvement for Patients and Providers Act of 2008

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 6331/S.3101 Medicare Improvements for Patients and Providers Act of 2008; S.3144/HR 6252 Medicare DMEPOS Competitive Acquisition Reform Act of 2008; Delay in competitive bidding for DME and supplies; Medicare Advantage; Comparative Effectiveness; ESRD; E-Prescribing; HR 4296/S 2408 Medicare Electronic Medication and Safety Protection Act of 2007 (E-MEDS); S. 691/HR 1193 Kidney Care Quality & Education Act of 2007; Special Need Plans (SNPs); H.R. 5613 Protecting the Medicaid Safety Net Act of 2008.

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 6331/S.3101 Medicare Improvements for Patients and Providers Act of 2008; Medicare Advantage; Comparative Effectiveness; ESRD; E-Prescribing; HR 4296/S 2408 Medicare Electronic Medication and Safety Protection Act of 2007 (E-MEDS); S. 691/HR 1193 Kidney Care Quality & Education Act of 2007. S. 3144/HR 6252 Medicare DMEPOS Competitive Acquisition Reform Act of 2008; Delay in competitive bidding for DME and supplies; H.R. 5613 Protecting the Medicaid Safety Net Act of 2008.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 6331/S.3101 Medicare Improvements for Patients and Providers Act of 2008; Medicare Advantage; Comparative Effectiveness; ESRD; E-Prescribing; HR 4296/S 2408 Medicare Electronic Medication and Safety Protection Act of 2007 (E-MEDS); S. 691/HR 1193 Kidney Care Quality & Education Act of 2007

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 6331/S.3101 Medicare Improvements for Patients and Providers Act of 2008; Medicare Advantage; Comparative Effectiveness; ESRD; E-Prescribing; HR 4296/S 2408 Medicare Electronic Medication and Safety Protection Act of 2007 (E-MEDS); S. 691/HR 1193 Kidney Care Quality & Education Act of 2007; Special Need Plans (SNPs)

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare and Medicaid reimbursement issues including Medicaid Rebate and Kidney Disease Education (S. 432/H.R. 1245, Kidney Disease Education Benefits Act of 2007; S. 691/H.R. 1193 Kidney Care Quality and Improvement Act of 2007); all issues related to Medicare coverage of pre-ESRD education. H.R. 2914 / S. 2990, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services; H.R. 6331 / S. 3101, Medicare Improvements for Patients and Providers Act, as it pertains to pre-dialysis education for certain M-care beneficiaries; S. 3118, Preserving Access to Medicare Act, as it pertains to pre-dialysis education for certain M-care beneficiaries: S. 558, Mental Health Parity Act, as it pertains to Medicaid rebates; H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act, as it pertains to Medicaid rebates, Medicare reimbursement issues.

Client expense: Not reported · Firm income: $57,500

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 691/H.R. 1193, The Kidney Care Quality and Education Act of 2007, provisions related to a permanent composite rate update and extension of Medicare Secondary Payer policy; S. 3101, Medicare Improvements for Patients and Providers Act of 2008; S. 3118, Preserving Access to Medicare Act of 2008; H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, provisions related to bundled payment system reform, permanent composite rate update and dialysis education and training sessions. Impact of Final Rule: ESRD Facility Conditions for Coverage Impact of Report to Congress: A Design for a Bundled End Stage Renal Disease Prospective Payment System

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE